Niche Science & Technology
Niche Science & Technology is a UK-based specialist clinical research organisation providing medical writing, regulatory strategy and clinical operations services to biotechnology companies, pharmaceutical sponsors and research organisations across the UK and Europe since 1998.
- Company typePrivate
- Founded1998
- HeadquartersRichmond, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Niche Science & Technology does
Niche Science & Technology Ltd is a UK-based specialist clinical research organisation founded in 1998, providing medical writing, regulatory strategy and clinical operations services to biotechnology companies, pharmaceutical sponsors and research organisations. The company operates from Richmond, London (with a registered office in Hyde, Cheshire) and delivers three core service pillars: Clinical Operations (clinical project management, trial master file management, study monitoring, site management), Regulatory Affairs (regulatory writing, strategy development, agency communications and submissions, QC review, legal representation), and Medical Communications (strategic communications, medical education, publication planning, medical illustration, grant applications). It also offers a branded offering called BioStack™. Services span from first-in-human studies through to marketing authorisation applications and publication planning, with documented contributions to EMA, FDA, MHRA and Health Canada approvals — including the world's first ex vivo autologous gene therapy (Strimvelis) and the antibiotic lefamulin.
The company's go-to-market is direct B2B enterprise engagement, with no reseller or marketplace channels. Lead generation is supported by a content-led strategy including the Insider's Insights practical guidance library, podcasts, case histories, and a free 48-hour Investigator Brochure review service personally delivered by Dr. Tim Hardman. Pricing is not publicly disclosed and is negotiated on a per-project basis. Customers span small and mid-size biotechs, larger pharmaceutical sponsors (ViiV Healthcare, Adaptimmune, Erytech, Nabriva, Orchard Therapeutics, Astex, Petrovax, EVERSANA), medical device firms (Cardionetics, ApaTech), academic research consortia (RASP-UK, MID-Frail, FRAILomic), and professional associations (British Society for Haematity). Several relationships exceed ten years in duration, indicating high retention. The company also manages large research consortia such as the £9.6 million MRC-funded RASP-UK initiative (since 2014) and rescued the €6 million EU Horizon 2020 MID-Frail study after the original CRO withdrew.
The firm operates as an independent, privately-held private limited company with 11-50 employees and no disclosed external funding, parent entity, or institutional investment. Geographic reach spans the UK and broader Europe (Ireland, France, Switzerland, Austria, Sweden, Germany, Belgium) with selected North American engagements, but no formal global footprint claim. The business model is professional services revenue earned through project-based contracts tied to clinical development programmes.
Niche Science & Technology firmographics
Firmographics- Name
- Niche Science & Technology
- Legal name
- Niche Science & Technology Ltd
- Website
- https://niche.org.uk
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Niche Science & Technology is a UK-based specialist clinical research organisation providing medical writing, regulatory strategy and clinical operations services to biotechnology companies, pharmaceutical sponsors and research organisations across the UK and Europe since 1998.
- Ownership category
- akta.pro rank
Niche Science & Technology industry classification
Industry- Product category
- Clinical Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)
Keywords
Where Niche Science & Technology is headquartered
LocationHeadquarters
- HQ city
- Richmond
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Niche Science & Technology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Clinical Research Services: Project-based professional services providing specialist medical writing, regulatory strategy and clinical operations support to biotechnology companies, pharmaceutical sponsors and research organisations. Revenue is generated through service contracts for clinical development programmes from first-in-human studies through to regulatory submissions and publication planning.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels8 records
Niche Science & Technology product offering
Product offeringCore offering
Niche Science & Technology is a specialist clinical research organisation (CRO) that provides medical writing, regulatory strategy, and clinical operations support to biotechnology companies, pharmaceutical sponsors, and research organisations. Services span from first-in-human studies through to regulatory submissions and publication planning, with deep expertise across UK and European regulatory frameworks including EMA, FDA, MHRA, and Health Canada. The company also offers a proprietary branded platform called BioStack™.
Product overview
Niche Science & Technology is a specialist clinical research organisation (CRO) providing medical writing and clinical research support services. The company operates as a service-based organisation rather than a software product company, offering three core service pillars: Clinical Operations, Regulatory Affairs, and Medical Communications. These services are delivered through a multidisciplinary team combining scientific depth with operational precision. The company also offers a branded product called BioStack™. Services span from first-in-human studies to publication planning and regulatory submissions, supporting biotechnology companies, pharmaceutical sponsors, and research organisations across the UK and Europe.
Differentiator
Problem solved
Functional benefit
Brands
- BioStack™: A product/service offering by Niche Science & Technology, referenced on the company's website navigation.
Products and services
- Clinical Operations Comprehensive clinical operations support covering clinical project management, trial master file and document management, study monitoring and site management, study documents, and quality and vendor management systems for biotechnology and pharmaceutical sponsors running clinical development programmes.
- Regulatory Affairs Regulatory strategy and writing services including regulatory writing, regulatory strategy development, agency communications and submissions, QC review and redaction, and legal representation for clinical development programmes.
- Medical Communications Strategic medical communications including strategic communications, medical education, editorial and quality control services, publication planning, medical illustration, and grant applications for clinical development sponsors.
- BioStack™ A proprietary branded platform or methodology referenced in the company's service portfolio, positioned as a specialised product offering for clinical research or document management.
Quantifiable outcome
- Supported Strimvelis to become world's first ex vivo autologous gene therapy to gain regulatory approval (EMA)
- +3 more outcomes
Companies that use Niche Science & Technology
Customer profileNamed customers33 records
Segments4 records
Ideal customer profiles3 records
Niche Science & Technology technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Niche Science & Technology partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- P95minorP95, a global CRO headquartered in Belgium, acquired Assign DMB (Niche's long-term client partner) in 2024, integrating their expertise with P95's global capabilities for epidemiology and clinical solutions.
- Cytel Inc.minorCytel Inc. acquired Scandinavian Development Services in 2022. Niche had partnered with SDS since 2013 providing regulatory writing services for Nordic clients.
- Medical Research Council (MRC)coreMRC co-funded the RASP-UK initiative with £9.6 million investment alongside Asthma UK and pharmaceutical partners. Niche has run the executive function of this consortium since 2014, overseeing seven clinical trials across 13 academic centres for severe asthma research.
- Asthma UKcoreCo-funder of the £9.6 million RASP-UK consortium alongside MRC. Partnership focused on transforming management of severe asthma through personalised treatment approaches and biomarker research.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Niche Science & Technology competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Niche Science & Technology social profiles
Digital presenceNiche Science & Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Niche Science & Technology leadership team
Management profileNumber of profiles
Profiles1 record
Niche Science & Technology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Niche Science & Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Niche Science & Technology
What does Niche Science & Technology do?
Niche Science & Technology is a specialist clinical research organisation (CRO) that provides medical writing, regulatory strategy, and clinical operations support to biotechnology companies, pharmaceutical sponsors, and research organisations. Services span from first-in-human studies through to regulatory submissions and publication planning, with deep expertise across UK and European regulatory frameworks including EMA, FDA, MHRA, and Health Canada. The company also offers a proprietary branded platform called BioStack™.
Is Niche Science & Technology a public or private company?
Niche Science & Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Niche Science & Technology founded?
Niche Science & Technology was founded in 1998. It employs 11 to 50 people.
Where is Niche Science & Technology based?
Niche Science & Technology is headquartered in Richmond, United Kingdom, in the Europe region.
How does Niche Science & Technology make money?
One revenue line is on record: clinical Research Services.
Does Niche Science & Technology have an API?
No public API is recorded for Niche Science & Technology.
What industry is Niche Science & Technology in?
Niche Science & Technology's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAH, Pharmacovigilance, Risk Management & Medical Affairs CROs. Its NAICS code is 5417 and its SIC code is 8731.